SEC Form 4 · accession 0001209191-15-046723
Karyopharm Therapeutics Inc. · KPTI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
J. Scott Garland
Director
Period of report
May 22, 2015
Accepted (ET)
May 26, 2015 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nonstatutory Stock Option (right to buy)F1 | $26.15 | May 22, 2015 | A | 10,000 | A | — | May 21, 2025 | Common Stock | 10,000 | 10,000 | D |
Explanation of responses
- F1This option vests as to 100% of the underlying shares on May 22, 2016, provided that the holder continues to serve as a director of the issuer through such date.